The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
The state of artificial intelligence-based FDA-approved medical devices and algorithms: an online database
Open accessAbstract
At the beginning of the artificial intelligence (AI)/machine learning (ML) era, the expectations are high, and experts foresee that AI/ML shows potential for diagnosing, managing and treating a wide variety of medical conditions. However, the obstacles for implementation of AI/ML in daily clinical practice are numerous, especially regarding the regulation of these technologies. Therefore, we provide an insight into the currently available AI/ML-based medical devices and algorithms that have been approved by the US Food & Drugs Administration (FDA). We aimed to raise awareness of the importance of regulatory bodies, clearly stating whether a medical device is AI/ML based or not. Cross-checking and validating all approvals, we identified 64 AI/ML based, FDA approved medical devices and algorithms. Out of those, only 29 (45%) mentioned any AI/ML-related expressions in the official FDA announcement. The majority (85.9%) was approved by the FDA with a 510(k) clearance, while 8 (12.5%) received de novo pathway clearance and one (1.6%) premarket approval (PMA) clearance. Most of these technologies, notably 30 (46.9%), 16 (25.0%), and 10 (15.6%) were developed for the fields of Radiology, Cardiology and Internal Medicine/General Practice respectively. We have launched the first comprehensive and open access database of strictly AI/ML-based medical technologies that have been approved by the FDA. The database will be constantly updated.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Dozens of companies have obtained US FDA and European CE approval for medical imaging AI 37 , and commercial markets have begun to form as sustainable business models are created.”
From Deep learning-enabled medical computer vision (2021) · cites this paper as [37]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The majority of AI interventions that are close to translation are in the field of medical diagnostics.3”
From Developing a reporting guideline for artificial intelligence-centred diagnostic test accuracy studies: the STARD-AI protocol (2021) · cites this paper as [3]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Moreover, diagnostics constitutes a substantial proportion of clinical AI focus, with most AI devices achieving regulatory approval thus far belonging to the diagnostic field 26 .”
From The STARD-AI reporting guideline for diagnostic accuracy studies using artificial intelligence (2025) · cites this paper as [26]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“To date, 64 AI-powered medical devices and algorithms have been approved by the Food and Drug Administration in the United States [8].”
From Randomized Controlled Trials of Artificial Intelligence in Clinical Practice: Systematic Review (2022) · cites this paper as [8]
The cited source says what the claim attributes to it.
In the citing paper
“Another obstacle to the implementation of AI or ML in daily clinical practice is the regulation of these technologies [8].”
From Randomized Controlled Trials of Artificial Intelligence in Clinical Practice: Systematic Review (2022) · cites this paper as [8]
7 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
High-performance medicine: the convergence of human and artificial intelligence
Topol, E. J. (2019) · Nature Medicine · doi:10.1038/s41591-018-0300-7 · Cited by 10,450 · cited 1×
“Despite its promise, the obstacles for implementation of AI/ML in daily clinical practice are numerous 10 .”
BackgroundWang, X., Peng, Y., Lu, L., Lu, Z., Bagheri, M., & Summers, R. M. (2017) · 2017 IEEE Conference on Computer Vision and Pattern Recognition (CVPR) · doi:10.1109/cvpr.2017.369 · Cited by 4,616
Deep Learning—A Technology With the Potential to Transform Health Care
Hinton, G. (2018) · JAMA · doi:10.1001/jama.2018.11100 · Cited by 667
Brown, J. M., Campbell, J. P., Beers, A., Chang, K., Ostmo, S., Chan, R. V. P., Dy, J., Erdogmus, D., Ioannidis, S., Kalpathy-Cramer, J., et al. (2018) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2018.1934 · Cited by 657 · cited 1×
“Indeed, AI/ML-based technologies have been shown to support several medical specialties from radiology 2 and oncology 3 to ophthalmology 4 and general medical decision-making 5 .”
BackgroundArtificial Intelligence in Health Care: A Report From the National Academy of Medicine
Matheny, M. E., Whicher, D., & Thadaney Israni, S. (2020) · JAMA · doi:10.1001/jama.2019.21579 · Cited by 628
Wang, X., Peng, Y., Lu, L., Lu, Z., Bagheri, M., & Summers, R. M. (2019) · Advances in Computer Vision and Pattern Recognition · doi:10.1007/978-3-030-13969-8_18 · Cited by 371 · cited 1×
“Indeed, AI/ML-based technologies have been shown to support several medical specialties from radiology 2 and oncology 3 to ophthalmology 4 and general medical decision-making 5 .”
BackgroundLabovitz, D. L., Shafner, L., Reyes Gil, M., Virmani, D., & Hanina, A. (2017) · Stroke · doi:10.1161/strokeaha.116.016281 · Cited by 311
Horng, S., Sontag, D. A., Halpern, Y., Jernite, Y., Shapiro, N. I., & Nathanson, L. A. (2017) · PLOS ONE · doi:10.1371/journal.pone.0174708 · Cited by 310
van der Heijden, A. A., Abramoff, M. D., Verbraak, F., van Hecke, M. V., Liem, A., & Nijpels, G. (2018) · Acta Ophthalmologica · doi:10.1111/aos.13613 · Cited by 296
Artificial intelligence and the future of psychiatry: Insights from a global physician survey
Doraiswamy, P. M., Blease, C., & Bodner, K. (2020) · Artificial Intelligence in Medicine · doi:10.1016/j.artmed.2019.101753 · Cited by 253
Research works printed but not linked: 1
- Wang, T. Outpatient clinic process enhancement at children’s hospital: empoweredby information technology. Chin. J. Hosp. Adm. 34, 753–755 (2018). http://wprim.whocc.org.cn/admin/article/articleDetail?WPRIMID=712592&articleId=713077.
Cited by
Rajpurkar, P., Chen, E., Banerjee, O., & Topol, E. J. (2022) · Nature Medicine · doi:10.1038/s41591-021-01614-0 · Cited by 3,212
Deep learning-enabled medical computer vision
Esteva, A., Chou, K., Yeung, S., Naik, N., Madani, A., Mottaghi, A., Liu, Y., Topol, E., Dean, J., & Socher, R. (2021) · npj Digital Medicine · doi:10.1038/s41746-020-00376-2 · Cited by 1,406
The imperative for regulatory oversight of large language models (or generative AI) in healthcare
Meskó, B., & Topol, E. J. (2023) · npj Digital Medicine · doi:10.1038/s41746-023-00873-0 · Cited by 1,047
Self-citationDiagnostic accuracy of deep learning in medical imaging: a systematic review and meta-analysis
Aggarwal, R., Sounderajah, V., Martin, G., Ting, D. S. W., Karthikesalingam, A., King, D., Ashrafian, H., & Darzi, A. (2021) · npj Digital Medicine · doi:10.1038/s41746-021-00438-z · Cited by 946
The Role of AI in Hospitals and Clinics: Transforming Healthcare in the 21st Century
Maleki Varnosfaderani, S., & Forouzanfar, M. (2024) · Bioengineering · doi:10.3390/bioengineering11040337 · Cited by 931
“For instance, in the United States, the Food and Drug Administration (FDA) is actively working on establishing clear guidelines for AI and machine learning-based medical devices [174].”
Background
Metadata
- Authors
- Benjamens, S., Dhunnoo, P., & Meskó, B.
- Affiliations
- University Medical Center Groningen (NL)
- Semmelweis University (HU)
- Corresponding author
- Meskó, Bertalan
- Venue
- npj Digital Medicine
- Published
- 2020-09-11
- Volume
- 3
- Issue
- 1
- Pages
- 118-118
- ISSN
- 2398-6352 (ISSN-L)
- PMC
- PMC7486909
- OpenAlex
- W3086667591
- Cited by
- 1,215
- References
- 24
- Citations by year
- 2026: 219 · 2025: 208 · 2024: 212 · 2023: 227 · 2022: 188 · 2021: 153 · 2020: 7
- FWCI
- 42.33
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- npj Digital Medicine (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (publishedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion, cc-by)
- Topics
- Health Sciences › Medicine › Health Informatics › Artificial Intelligence in Healthcare and Education
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Healthcare Regulation
- Physical Sciences › Computer Science › Information Systems › Internet of Things and AI
- Keywords
- artificial intelligence, machine learning, medical device regulation, 510(k) clearance, de novo pathway, premarket approval, clinical implementation of AI, radiology, online databases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The state of artificial intelligence-based FDA-approved medical devices and algorithms: an online database. https://app.cochat.ai/papers/10.1038/s41746-020-00324-0
- The paper
- Benjamens, S., Dhunnoo, P., & Meskó, B. (2020). The state of artificial intelligence-based FDA-approved medical devices and algorithms: an online database. npj Digital Medicine. https://doi.org/10.1038/s41746-020-00324-0
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.